JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

ISSN: Active
eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Evaluation of demographic and clinical data of patients diagnosed with lung cancer: a single-center experience
Abstract
Aims: To retrospectively evaluate the demographic, epidemiological, and clinical characteristics of patients diagnosed with lung cancer.
Methods: Patients diagnosed and treated for lung cancer in our medical oncology clinic were included in the study. Patient records were obtained retrospectively from the electronic databases of the hospital. Demographic and clinical characteristics were recorded for each patient.
Results: A total of 313 patients diagnosed with lung cancer were included in the study. Mean age was 62.7 ± 10.3 years. Of the patients, 83.4% were male and 16.6% were female. Most common presenting complaints were dyspnea (40.9%) and chest pain (32.2%). Smoking history was present in 66.5% of patients, and 15.3% had a history of tandoori smoke exposure. Radiologically, the most frequent tumor localization was the right upper lobe (38%). Most common histopathological types were squamous cell carcinoma (39.3%), adenocarcinoma (27.2%), and small cell carcinoma (20.1%). Most common disease stage at the time of diagnosis was stage IV (48.9%), followed by stage III (39%), II (10.9%), and I (1.3%). Mean OS was 14 ± 1.4 (range, 11.2–16.8) months. Higher ECOG performance scores and advanced stage were associated with poorer survival. Mean OS was 31 months for females and 13 months for males.
Conclusion: The findings obtained in our study were found to be consistent with those of previous research. In Turkey, the high prevalence of smoking, the asymptomatic nature of the disease, and the tendency of patients to attribute existing symptoms to smoking appear to contribute to delayed presentation to healthcare facilities, which likely plays a role in the high proportion of advanced-stage diagnoses. Additionally, unlike in other studies, the higher proportion of female patients diagnosed in our cohort was considered to be related to the widespread use of tandoori ovens in our region.

Keywords : Lung cancer, smoking, demographic

Download Article


1. Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments.Lancet. 2017;389(10066):299-311. doi:10.1016/S0140-6736(16)30958-8
2. Dindar Çelik F, Çakır E, Gülbağcı B, Demirci A, Varım C, Bilir C. Sakarya Üniversitesi Tıbbi Onkoloji Kliniği 2017-2018 yılı akciğer kanseri istatistikleri. J Human Rhythm. 2020;6:8-14.
3. Salehi-Rad R, Li R, Paul MK, Dubinett SM, Liu B. The biology of lung cancer: development of more effective methods for prevention, diagnosis, and treatment.Clin Chest Med. 2020;41(1):25-38. doi:10.1016/ j.ccm.2019.10.003
4. Kılıç N, Cansaran Duman D. Akciğer kanseri tedavisinde farmakogenomik. Turk Hij Den Biyol Derg. 2017;74:175-184. doi:10. 5505/TurkHijyen.2017.21703
5. Spiro SG, Porter JC. Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.Am J Respir Crit Care Med. 2002;166(9):1166-1196. doi:10.1164/rccm.200202-070SO
6. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD,https://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011.
7. Yang P, Allen MS, Aubry MC, et al. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest. 2005;128(1):452-462. doi:10.1378/chest.128.1.452
8. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases.Ann Oncol. 2002; 13(7):1087-1093. doi:10.1093/annonc/mdf187
9. Günlüoğlu, G, Altın, S, Timur, S, at al. An update for demographics of lung cancer using data of an educational hospital in İstanbul. Solunum. 2012;14(1):14-17. doi:10.5505/solunum.2012.68736
10. Bircan H, Öztürk Ö, Şahin Ü, Özaydın N, Akkaya A. Akciğer kanseri tanısı alan olgularımızın retrospektif değerlendirilmesi. Med J SDU. 2005;12(3):1-6.
11. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142(4):233-239. doi:10.7326/0003-4819-142-4-200502150-00005
12. Erbaycu AE, Batum Ö, Gülpek M, et al. Akciğer kanserli hastaların teşhis anındaki semptomları: 3547 hastanın analizi. İzmir Göğüs Hastanesi Derg. 2009;23(2):71-76.
13. Spiro SG, Gould MK, Colice GL; American College of Chest Physicians. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 suppl): 149S-160S. doi:10.1378/chest.07-1358
14. Türk Toraks Derneği, Akciğer ve Plevra Maligniteleri Çalışma Grubu. Türkiye’nin akciğer kanseri haritası projesi: Türkiye’nin akciğer kanseri insidensi. Türk Toraks Derneği. 2005;13.
15. Özsu S, Özlü T. Türkiye’de akciğer kanseri epidemiyolojisi. Güncel Göğüs Hastalıkları Serisi. 2013;1(3):7-11.
16. Sen E, Kaya A, Erol S, Savaş I, Gönüllü U. Kadınlarda akciğer kanseri: klinik özellikler ve sağkalıma etkili faktörler. Tuberk Toraks. 2008; 56(3):266-274.
17. Doğan M, Yalçın S, Üneşi Ş. Kırıkkale ilinde küçük hücre dışı akciğer kanseri tanılı hastaların retrospektif değerlendirilmesi. Ortadoğu Med J. 2018;10(2)103-109. doi:10.21601/ortadogutipdergisi.335600
18. Kefeli U, Ustaalioğlu BÖ, Ustaalioğlu BBÖ, et al. Akciğer kanserinde sağkalımı etkileyen klinikopatolojik özellikler. Marmara Med J. 2015; 28(1):21-26. doi:10.5472/mmj.2015.03731.1
19. Gönlügür U, Akkurt İ, Kaptanoğlu M, Efeoğlu T. 80 primer akciğer kanserinin retrospektif analizi. İzmir Göğüs Hastanesi Derg. 2003;17(2): 59-63.
20. Akkoçlu A. Akciğer kanserleri. Türk Toraks Derneği. 2006.
21. Paralkar VR, Li T, Langer CJ. Population characteristics and prognostic factors in metastatic non-small-cell lung cancer: a Fox Chase Cancer Center retrospective. Clin Lung Cancer. 2008;9(2):116-121. doi:10.3816/CLC.2008.n.018
Article available in :
Volume 4, Issue 1, 2026
Page : 12-17
https://doi.org/10.51271/JCHOR-0075
Article Information
Received : 12 Ara 2025
Accepted : 09 Oca 2026
Published : 25 Şub 2026
Corresponding Author :

Senar Ebinç: Department of Medical Oncology, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Turkiye

[email protected]
Citation : Kayran MM, Aldemir MN, Aydemir O, Erdem M, Erzen Ş, Ebinç S. Evaluation of demographic and clinical data of patients diagnosed with lung cancer: a single-center experience. J Curr Hematol Oncol Res. 2026;4(1):12-17.

Read: 44
Download : 49
Cited: 0
_Footer